Evidence map›Paper›PMID 39780213›Full record

ArticleHereditary cancer in clinical practice2025

Two independent families with de novo whole APC gene deletion and intellectual disability: a case report.

Moriya Iwaizumi, Terumi Taniguchi, Risa Kojima, Harumo Osawa, Kyota Tatsuta, Mayu Sakata, Satoshi Osawa, Kiyotaka Kurachi, Ken Sugimoto

Abstract read
In one paragraph

Article in Hereditary cancer in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moriya IwaizumiDepartment of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. iwaizumi@hama-med.ac.jp.
Terumi TaniguchiDepartment of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Risa KojimaClinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Harumo OsawaClinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Kyota TatsutaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Mayu SakataDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Satoshi OsawaDepartment of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Kiyotaka KurachiClinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Ken SugimotoFirst Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.

Funding

Japan Society for the Promotion of Science 22K08053
6 · The paper itself

Abstract

backgroundFamilial adenomatous polyposis (FAP) is an autosomal dominant colorectal tumour syndrome characterised by the formation of multiple adenomatous polyps throughout the colon. It is important to understand the extracolonic phenotype that characterizes FAP. Most previous case reports of patients with both FAP and intellectual disability (ID) have described deletions in all or part of chromosome 5q, including the APC locus. However, it remains unclear whether the ID phenotype in patients with FAP is due to APC disruption or another genetic defect in the deleted 5q region. CASE PRESENTATION: Patient of family 1 is a 32-year-old woman presented with > 500 colorectal adenomatous polyps, gastric fundic gland polyposis, several duodenal adenomas, and mild intellectual disability (ID). She had no known family history of the FAP phenotype or ID. By copy number trio analysis, a 15.4 Mb interstitial heterozygous de novo deletion including APC region was observed in 5q21.2. q22.3. The patient in family 2 was a 29-year-old man with approximately 50 colorectal adenomatous polyps, fundic gland polyposis in the stomach, non-ampullary adenomas in the duodenum, and mild ID. He had no family history of the FAP phenotype or ID. Using copy number trio analysis, a de novo 9.8 Mb heterozygous deletion was identified on 5q22.1. q23.1 which includes the APC region.

conclusionsBased on previous reports and the present study, we narrowed down the 5p deletion region associated with ID in FAP. Further investigation is required to understand ID due to 5q stromal deletion.

Indexed as

APC geneChromosome 5q deletionDe novo mutationFamilial adenomatous polyposisIntellectual disabilityWhole APC deletion

Identifiers

PMID39780213
PMCPMC11708175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.